Relationship of LVEF and Myocardial Scar to Long-Term Mortality Risk and Mode of Death in Patients With Nonischemic Cardiomyopathy
Top Cited Papers
- 6 April 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 143 (14), 1343-1358
- https://doi.org/10.1161/circulationaha.120.048477
Abstract
Background: Non-ischemic cardiomyopathy (NICM) is a leading cause of reduced left ventricular ejection fraction (LVEF) and is associated with high mortality risk from progressive heart failure and arrhythmias. Myocardial scar on cardiovascular magnetic resonance imaging (CMR) is increasingly recognized as risk marker for adverse outcomes, however LV dysfunction remains the basis for determining a patient's eligibility for primary prophylaxis implantable cardioverter-defibrillator (ICD). We wanted to investigate the relationship of LVEF and scar to long term mortality and mode of death in a large cohort of patients with NICM. Methods: This study is a prospective, longitudinal outcomes registry of 1020 consecutive patients with NICM who underwent clinical CMR for the assessment of LVEF and scar at three centers. Results: During a median follow-up of 5.2 (IQR 3.8, 6.6) years 277 (27%) patients died. On survival analysis LVEF≤35% and scar were strongly associated with all-cause (log-rank test p=0.002 and pConclusions: Myocardial scar and LVEF are both risk markers for all-cause and cardiac death in patients with NICM. However, while myocardial scar has strong and incremental prognostic value for SCD risk stratification, LVEF has no incremental prognostic value over clinical parameters. Scar assessment should be incorporated into patient selection criteria for primary prevention ICD placement.This publication has 37 references indexed in Scilit:
- Prediction of Arrhythmic Events in Ischemic and Dilated Cardiomyopathy Patients Referred for Implantable Cardiac DefibrillatorCirculation: Cardiovascular Imaging, 2012
- Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure PopulationCirculation, 2009
- Use and Misuse of the Receiver Operating Characteristic Curve in Risk PredictionCirculation, 2007
- Costs and Quality-of-Life Effects of Implantable Cardioverter-DefibrillatorsThe American Journal of Cardiology, 2006
- Contemporary Definitions and Classification of the CardiomyopathiesCirculation, 2006
- ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina—Summary ArticleCirculation, 2003
- Standardized Myocardial Segmentation and Nomenclature for Tomographic Imaging of the HeartCirculation, 2002
- Classification of death in antiarrhythmia trialsJournal of the American College of Cardiology, 1996
- Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy.JCI Insight, 1993
- Sudden death in idiopathic dilated cardiomyopathyAmerican Heart Journal, 1992